Dissociated effect of amphotericin B and desoxycholate on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils. 1985

E Lingaas, and T Midtvedt

The influence of commercial amphotericin B-desoxycholate (Fungizone) and desoxycholate alone on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils in vitro was studied. A dissociated effect of amphotericin B and desoxycholate was observed. Amphotericin B was shown to stimulate the ingestion of Escherichia coli through an effect on the bacteria as well as on the neutrophils. Desoxycholate inhibited phagocytosis through an effect on the neutrophils and also, at low concentrations (0.08 microgram/ml), through an effect on the bacteria. On the other hand, pretreatment of Escherichia coli with high concentrations (8.2 micrograms/ml) of desoxycholate rendered it more susceptible to phagocytosis. The elimination of bacterial breakdown products from the neutrophils after ingestion of Escherichia coli was also inhibited by desoxycholate and stimulated by amphotericin B. Most of these effects disappeared in the presence of 10% serum. An alteration of bacterial hydrophobicity could only partly explain the effect of amphotericin B.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D003840 Deoxycholic Acid A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Deoxycholate,Desoxycholic Acid,Kybella,Choleic Acid,Deoxycholic Acid, 12beta-Isomer,Deoxycholic Acid, 3beta-Isomer,Deoxycholic Acid, 5alpha-Isomer,Deoxycholic Acid, Disodium Salt,Deoxycholic Acid, Magnesium (2:1) Salt,Deoxycholic Acid, Monoammonium Salt,Deoxycholic Acid, Monopotassium Salt,Deoxycholic Acid, Monosodium Salt,Deoxycholic Acid, Sodium Salt, 12beta-Isomer,Dihydroxycholanoic Acid,Lagodeoxycholic Acid,Sodium Deoxycholate,12beta-Isomer Deoxycholic Acid,3beta-Isomer Deoxycholic Acid,5alpha-Isomer Deoxycholic Acid,Deoxycholate, Sodium,Deoxycholic Acid, 12beta Isomer,Deoxycholic Acid, 3beta Isomer,Deoxycholic Acid, 5alpha Isomer
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

E Lingaas, and T Midtvedt
July 1975, Infection and immunity,
E Lingaas, and T Midtvedt
October 1993, Enfermedades infecciosas y microbiologia clinica,
E Lingaas, and T Midtvedt
April 1972, Journal of the Reticuloendothelial Society,
E Lingaas, and T Midtvedt
January 1994, Methods in enzymology,
E Lingaas, and T Midtvedt
September 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
E Lingaas, and T Midtvedt
March 1982, Inflammation,
Copied contents to your clipboard!